Group items tagged

Community pharmacies are well placed to play a role in preventing deaths from cardiovascular disease (CVD) said Director of NHS Services. The recent analysis by the British Heart Foundation (BHF) revealed that nearly 100,000 more people with cardiovascular disease than expected have died since the start of the pandemic in England. Latest figures show that the number of people waiting for time-sensitive cardiac care was at a record high of nearly 390,000 at the end of April in England. Average ambulance response times for heart attacks and strokes have consistently been above 30 minutes since the beginning of 2022, and in December 2022 they even breached 90 minutes. The target is 18 minutes, though the Government has set a new average target of 30 minutes over 2023/24. Director of NHS Services, Alastair Buxton, said: "It is concerning to hear that there have been tens of thousands of preventable deaths from cardiovascular disease (CVD) since the start of the COVID-19 pandemic. We share BHF's desire to see more action on preventing the causes of CVD and, subject to appropriate funding being in place, community pharmacy teams are well placed to play a role in this.

This CME/CE course on Cardiovascular Health in Postmenopausal Women explores data on cardiovascular disease in this demographic, covering incidence, impact, underlying causes, and associated risk factors.

The National Institute for Health and Care Excellence (NICE) has recommended icosapent ethyl also called Vazkepa manufactured by Amarin for adults who have cardiovascular disease with controlled LDL-C levels taking a statin. It's final draft guidance is expected to be available on the July 20. Nearly half a million people are expected to benefit from the first licensed treatment shown to reduce the risk of heart attacks and strokes in people with controlled low-density lipoprotein cholesterol (LDL-C - sometimes called "bad" cholesterol) who are taking a statin and who have raised levels of triglycerides. NICE said: "Clinical trial evidence suggests that for people with raised triglycerides who have LDL-C levels controlled by statins, and who have cardiovascular disease, icosapent ethyl reduces their risk of cardiovascular events by over a quarter compared with placebo. Helen Knight, interim director of medicines evaluation at NICE, said: "Icosapent ethyl is the first licensed treatment of its kind for people who are at risk of heart attacks and strokes despite well controlled LDL cholesterol because they have raised blood fats. And although lifestyle changes, including diet and exercise, can help to reduce their risk, these may not work for everyone.

Community pharmacies will be able to deliver approximately 15 million blood pressure screenings by 2026, revealed the Company Chemists' Association (CCA)'s new research. This will also prevent 15,000 people from suffering heart attacks or strokes. CCA has called the Government to take up their offer and commission pharmacies as the first port of call for cardiovascular care. "Thousands of lives can be saved with ambitious commissioning and the investment to match," said CCA. There is an opportunity to use the expertise of community pharmacy to go further and provide the care these newly identified patients' need. To do this the sector needs funding and workforce. The association said: "Community pharmacy is under great financial pressure, suffering a real term funding cut of over 30% over 8 years. With funding, the sector can transform to deliver this critical need for patients. Whilst there are plans to train Independent Prescribers (IPs), there are no clear roles for them to use these skills. There is a need to accelerate training plans to allow pharmacists to deliver the service described here and play their part in CVD management."

There are multiple causes of snoring and some of them are not detrimental to health. Those can be easily cured just by changing your sleeping postures or curbing on your habit of excessive alcohol consumption. Scientists have now found out after a long-time research that obstructive sleep apnea results from a serious disorder and can up the risk of cardiovascular problem. It could indicate breaking down of cells in your veins. Link between Snoring and Heart Disease However, snoring can be a symptom of serious health issues, including cardiovascular problems. Let us take a quick look at how snoring could be a red flag for your heart health. A recent study by a group of doctors at Columbia University has identified a chain of events that define how the damage is caused in a step-wise manner. Of several problems that could cause heart attack is high blood pressure. If obstructed sleep apnea is not treated properly or in time, it could cause high blood pressure which may result in increased size of the heart, thereby being an alarming signal for strokes and heart attack.

Low levels of sodium are recommended for heart and high blood pressure patients, so salt intake has to cut down which further decreases chloride levels, And lower chloride levels also ups risk of cardiovascular disease.

According to the latest findings from the Centers for Disease Control (CDC), cardiovascular disease-an umbrella term that includes heart attacks, stroke, arrhythmia and several other conditions-is the leading cause of death in the United States. Of course, many things can contribute to the formation of cardiovascular disease, including genetics and countless lifestyle choices.

Cardiovascular disease kills more people each year than any other disease. How much do we really know about our heart’s health? Learn heart disease myths and facts published in doctor Gokhale website.

Good morning friends,starting from this post onwards i will try to explain some changes the human body undergoes during pregnancy.Today I'll make an attempt to explain the cardiovascular changes in pregnancy[heart & the circulatory system]

The UK must act swiftly to fend off competition if it wants to build the world's leading life sciences sciences hub, a new report suggests. A year on from the launch of the government's life science vision, the report commissioned by the the Association of the British Pharmaceutical Industry said although achieving the ambition remained feasible, the UK would need an attractive business environment because its competitor countries were becoming more adept at attracting investment. To achieve the ambition of the vision, the PwC-produced report suggested raising pharmaceutical R&D investment in the UK to build a 'stronger manufacturing and research infrastructure', alongside better investment in, access to and uptake of innovative medicines. It said the UK would also need to adopt a renewed approach to the priority healthcare challenges identified in the government's 'Life Science Vision', which would mean cutting the overall burden on health of dementia, cancer, cardiovascular and respiratory disease and mental health. The report quantified the size of the prize if the vision was implemented in full and the UK could emulate the successes of leading EU countries, which included: £68 billion in additional GDP over 30 years, owing to increased R&D investment £16.3 billion additional annual GDP from increased pharmaceutical exports Supporting 85,000 additional jobs Up to 40 per cent decrease in disease burden across the whole UK - for areas like cardiovascular disease, mental health conditions and Cancer. Reduced variation in speed of access to new medicines within three months of licensing for all NHS patients.

Use of cholesterol lowering drugs may significantly cut cardiovascular risks, but its long term use can raise the risk of developing cataracts by 27 percent, researchers have found.

Wegovy maker Novo Nordisk said on Tuesday (Aug 8) a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving beyond its image as a lifestyle drug. The increasingly popular Wegovy has transformed the weight-loss market since its U.S. launch in June 2021, capturing the attention of patients, investors and celebrities worldwide. Novo's news lifted shares in Europe's second-most valuable listed company after LVMH by more than 17 per cent to record highs. They have now surged almost 165 per cent over the past two years. The results of the late-stage trial may help persuade insurers in the U.S. and cost-conscious health authorities in Europe to cover the cost of Wegovy, which is $1,300 a month in the United States, for a wider range of patients. U.S. law classifies weight-loss treatments as lifestyle drugs and bars the Medicare health plan for older Americans from covering them and experts said the new data could lead the U.S. government to reassess that.

The Department of Health and Social Care (DHSC) has invited views of healthcare professionals and others to tackle the six major health conditions which drive-ill health and contribute to the burden of disease in England. The six major health conditions - cancer; cardiovascular diseases including stroke and diabetes; chronic respiratory diseases; dementia; mental ill-health and musculoskeletal disorders - affect millions of people in England with data showing that one in four suffer from two or more of these major long-term conditions. Recognising the pressure these conditions are putting on the NHS, the government is seeking views on a new strategy to tackle them that will focus not only on treatment but also on prevention. Government is particularly interested in hearing from those who suffer from, care for or provide treatment to people who suffer from multiple long-term conditions. This is to ensure the Major Conditions Strategy is one that will better prevent, diagnose, manage and treat these conditions. Contributions are also encouraged from those working in NHS bodies, local government, the voluntary and community sector, and wider industry, on how best to tackle suffering from one or more of these major conditions. Particularly, it is seeking perspectives on how government and the NHS can work better together with different organisations and sectors to improve the nation's health.

In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative cardiometabolic clinic. The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust. This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack. Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together. "We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."

Cardiovascular disease is the number one cause of death and number one cause of hospitalization in developed countries. Statin drugs are a common drug of choice in the prevention (lower cholesterol) and treatment of heart disease. The research is quite compelling showing the benefits of statin therapy. However does everyone need a statin?

Sweet potato is a tuber that grows under the ground. It is a rich source of beta-carotene, an anti-oxidant that adds to blood level of vitamin A, especially in the children. Sweet potatoes are highly nutritious and also taste very delicious. The starch-rich tuber belongs to the family of Convolvulaceae. Its botanic name is Ipomoea batatas. Its flesh is crunchy and rich in flavored anti-oxidant pigment, minerals, vitamins and dietary fiber, all of which are beneficial to keep your health in the fine fettle. It is very good for one's optimal cardiovascular health. Sweet potatoes are consumed in different ways but usually taken boiled, fried, steamed or baked. Nutritional Facts of Sweet Potato

Atkins Diet Weight Loss Program, despite its high fat content, has many health benefits that promote cardiovascular health.

Power Wheelchair Uses for Handicapped Person A motorized wheelchair, power-chair, Electric Wheelchair or electric-powered wheelchair (EPW) is a wheelchair that is propelled by means of an electric motor rather than manual power. Motorized wheelchairs are useful for those unable to propel a manual wheelchair or who may need to use a wheelchair for distances or over terrain which would be fatiguing in a manual wheelchair. They may also be used not just by people with 'traditional' mobility impairments, but also by people with cardiovascular and fatigue based conditions. http://www.wheelchairindia.com/ http://onlywheelchair.blogspot.in/2014/10/power-wheelchair-uses-for-handicapped.html

A motorized wheelchair, Electric Wheelchair or electric-powered wheelchair (EPW) is a wheelchair that is propelled by means of an electric motor rather than manual power. Motorized wheelchairs are useful for those unable to propel a manual wheelchair or who may need to use a wheelchair for distances or over terrain which would be fatiguing in a manual wheelchair. They may also be used not just by people with 'traditional' mobility impairments, but also by people with cardiovascular and fatigue based conditions. Price starts from 88138,109505,139500 INR,2,272.19 USD

Tricycles are mobility devices that can be custom built for individuals with disabilities that inhibit their ability to ride a typical bike or tricycle. Some of these disabilities include, but are not limited to, Cerebral Palsy, Spina Bifida, Muscular Dystrophy, Angelman Syndrome, Rett Syndrome, Down Syndrome, and visually impaired. These tricycles offer a multitude of features that can benefit your child or youth, to allow them the joy of bike riding. Buy online Tricycle For Disabled People at lowest price and cheap cost in india from wheelchair india online shopping store of Tricycle manufacturer, distributor, dealer and supplier of variety of Tricycles at low price in india for handicapped. Some features include: increased trunk support, rear control steering, assisted pedaling, adjustable handlebars, and foot strapping. By utilizing a Concepts Tricycle as part of your child's physical therapy treatment you are providing them with a fun activity as well as cardiovascular benefits, stimulation of reciprocal leg movement which is essential for walking and crawling, muscular strengthening and endurance training, vestibular stimulation, and upper extremity use for activities such as steering. Many children start out on a tricycle before moving on to a bike. Tricycles offer a safe way for toddlers and young children to begin developing the skills necessary to balance and ride on two wheels. Adults can get enjoyment out of tricycles as well as building strength and improving fitness. The stability offered by having a third wheel is just one reason why tricycles make a good choice for fun and exercise at any age. In addition to providing Concepts Tricycles for treatment purposes, Starfish Therapies is also an assessment center and can assist you in finding the perfect tricycle for your child. Visit Wheelchair india for more information about their Tricycle For Handicapped Children products. Please contact us to find out how this piece of equipment can b